Anthropometric Assessment

Body Mass Index (BMI) Calculator

Compute your clinical BMI score and healthy weight target corridor with dual US Imperial and Metric systems. Grounded in World Health Organization epidemiology.

Anthropometric Metric Model

Real-time calculation • Dual US Imperial (lbs, ft/in) / Metric (kg, cm)

Body Weight

lbs

Height (Feet)

Height (Inches)

Calculates Quetelet's index: mass (kg) / height (m)². World Health Organization international classification.

BMI Assessment

WHO Standard

Your Body Mass Index

23.7

Normal Weight (Healthy)

Underweight (<18.5) Normal (18.5-24.9) Overweight (25-29.9) Obesity (30+)

Healthy Weight Corridor For Your Height:

129 – 174 lbs

Maintaining your mass within this target corridor minimizes all-cause mortality and cardiometabolic incidence risks according to the Global BMI Mortality Collaboration.

Clinical Evidence & Methodology

Clinical Evaluation of Body Mass Index (BMI)

Clinically Reviewed by Dr. Julian Vance, MD, FACP • Updated September 2026

1. WHO International Weight Classifications

The Body Mass Index (BMI), originally formulated by Belgian polymath Adolphe Quetelet in 1832, represents an epidemiological metric assessing weight-for-height proportionality. The World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC) establish the following standard adult thresholds:

Underweight: BMI < 18.5 kg/m² (associated with nutrient deficiencies, osteoporosis, and compromised immune resilience).
Normal Weight (Healthy): BMI 18.5 – 24.9 kg/m² (statistically associated with the lowest all-cause morbidity and mortality).
Overweight (Pre-Obesity): BMI 25.0 – 29.9 kg/m² (elevated risk profile for dyslipidemia, hypertension, and hepatic steatosis).
Class I Obesity: BMI 30.0 – 34.9 kg/m² (moderate cardiometabolic risk).
Class II Obesity: BMI 35.0 – 39.9 kg/m² (severe risk of Type 2 diabetes, ischemic heart disease, and obstructive sleep apnea).
Class III Obesity (Morbid): BMI ≥ 40.0 kg/m² (very high clinical complication profile).

2. Critical Clinical Limitations & Body Composition Distinctions

While BMI provides robust clinical utility as a low-cost screening tool in large population cohorts, clinicians emphasize its physiological shortcomings in individual diagnostics:

Inability to Differentiate Tissue Compartments: BMI cannot distinguish between skeletal muscle hypertrophy and visceral adipose tissue. Resistance-trained athletes frequently register in the "overweight" or "obese" categories despite possessing sub-12% body fat percentages.
Sarcopenic Obesity in Geriatric Populations: Elderly individuals may experience muscle wasting accompanied by visceral fat accumulation while maintaining a "normal" BMI, masking profound cardiometabolic risk.
Ethnic Phenotype Variations: WHO consensus panels highlight that populations of South Asian and East Asian ancestry present elevated cardiovascular and diabetic complications at lower BMI cutoffs (overweight at ≥23.0 kg/m²; obesity at ≥27.5 kg/m²).

Clinical Diagnostic Recommendation

Physicians recommend pairing BMI screening with waist circumference measurements, lipid panel biomarker testing, and body composition analysis (e.g., U.S. Navy circumference method or DEXA scans) to accurately assess cardiometabolic health.

3. Peer-Reviewed Citations

The Global BMI Mortality Collaboration. (2016). Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. The Lancet, 388(10046), 776-786. PMID: 27423262.
World Health Organization. (2000). Obesity: preventing and managing the global epidemic. WHO Technical Report Series, 894.
Romero-Corral, A., et al. (2008). Accuracy of body mass index in diagnosing obesity in the adult general population. International Journal of Obesity, 32(6), 959-966. PMID: 18283284.
WHO Expert Consultation. (2004). Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. The Lancet, 363(9403), 157-163.